Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein
Year: 2008
Type: article
Abstract: alpha-Synuclein (alpha-syn) phosphorylation at serine 129 is characteristic of Parkinson disease (PD) and related alpha-synulceinopathies. However, whether phosphorylation promotes or inhibits alpha-syn aggregation and neurotoxicity in vivo remains unknown. This understanding is critical for elucidating the role of alpha-syn in the pathogenesis of PD and for development of therapeutic strategies for PD. To better understand the structural and molecular consequences of Ser-129 phosphorylation, we compared the biochemical, structural, and membrane binding properties of wild type alpha-syn to those of the phosphorylation mimics (S129E, S129D) as well as of in vitro phosphorylated alpha-syn using a battery of biophysical techniques. Our results demonstrate that phosphorylation at Ser-129 increases the conformational flexibility of alpha-syn and inhibits its fibrillogenesis in vitro but does not perturb its membrane-bound conformation. In addition, we show that the phosphorylation mimics (S129E/D) do not reproduce the effect of phosphorylation on the structural and aggregation properties of alpha-syn in vitro. Our findings have significant implications for current strategies to elucidate the role of phosphorylation in modulating protein structure and function in health and disease and provide novel insight into the underlying mechanisms that govern alpha-syn aggregation and toxicity in PD and related alpha-synulceinopathies.
Source: Journal of Biological Chemistry
Institutions: École Polytechnique Fédérale de Lausanne, Weill Cornell Medicine, Max Planck Society, Max Planck Institute for Biophysical Chemistry, Consejo Nacional de Investigaciones Científicas y Técnicas, National University of Rosario, Instituto de Biología Molecular y Celular de Rosario, Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,430
Funders: National Science Foundation, Alexander von Humboldt-Stiftung, Deutsche Forschungsgemeinschaft, École Polytechnique Fédérale de Lausanne, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Max-Planck-Gesellschaft, National Institutes of Health, National Institute on Aging, National Institute of General Medical Sciences
Awards: Structure and Function of Tau, Structure and function of alpha-synuclein, Structure and Function of Alpha-Synuclein, Elucidating the structural basis of protofibrils associated toxicity in Alzheimer's and Parkinson's disease using molecular electron microscopy, 900 MHz NMR Spectrometer for Structural Biology, G7824720858, G9000094262
OpenAlex ID: W2031964854
